问题 › 我们的营销支出没有效果 › 律所
多数营销无法提升每权益合伙人利润，是因为渠道从未触及真正委托收费律师的客户，且衡量方式与变现率或锁定期天数完全脱钩。 在律所，这一问题有具体表现。关键数字是82%变现率和68%利用率，行业特有难点是28名权益合伙人中有19人已55岁以上，且八年未设正式横向招聘或律师转合伙人通道。通用问题与你实际面对的问题，首步动作不同。
多数营销无法提升每权益合伙人利润，是因为渠道从未触及真正委托收费律师的客户，且衡量方式与变现率或锁定期天数完全脱钩。 在律所，这一问题有具体表现。关键数字是82%变现率和68%利用率，行业特有难点是28名权益合伙人中有19人已55岁以上，且八年未设正式横向招聘或律师转合伙人通道。通用问题与你实际面对的问题，首步动作不同。
两种不同失误会产生同一抱怨。渠道从未生成权益合伙人愿意入账的案件，此时增加预算只会拉大£24.8 m总收入与£184 k每权益合伙人利润之间的差距。或者渠道生成了案件，但报告从未追踪到五个业务组，支出仅按询盘量评价，而非利用率或112天锁定期。
区分两种失误首先是衡量问题。若无法按渠道和业务组给出每个新案件成本，再多的合伙人活动或宣传册修订也无法解决争论，预算将由最自信的权益合伙人决定。
第二个问题是回款而非数量。能获取高变现率、短锁定期案件的渠道值得投入；获取低变现率、延长112天锁定期案件的渠道则不值得，无论询盘数量如何。
这三者同时出现才是标志。单独一个通常指向其他问题。
✓ 每权益合伙人利润保持不变，而权益合伙人却报告询盘或网站访问量上升。
✓ 支出辩护靠询盘或活动数量，而非五个业务组的利用率或变现率变化。
✓ 哪个业务组表现最好，取决于报告来自营销合伙人还是财务合伙人。
通常会让情况更糟的做法。 在修复衡量前先优化合伙人活动内容或宣传册定向，用无法连接支出与变现率、利用率或锁定期天数的数据做出自信的预算决定。
It is for you if you run or finance a law firm and cost per acquisition cannot be stated by channel. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on 一家律所. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is Ashgrove Legal LLP, a sample company profile used for testing rather than a customer — £24.8 m gross revenue from five practice groups.
Excerpt from a real Percision run · Competitive Positioning · sample company profile
The move. Scale the only practice hitting 88 % realisation to fund its own growth and close the succession gap.
| Investment required | £240 k (remaining FY2026 discretionary cap after £180 k IT commitment) |
| Expected return | 1.4–1.6× cash-on-cash within 24 months at current realisation rates. |
| Revenue, year 1 | £25.4–25.7 m firm-wide (+£0.6–0.9 m incremental) |
| Revenue, year 2 | £26.5–27.1 m firm-wide (+£1.1–1.3 m incremental from B&F segment) |
| Revenue, year 3 | £27.8–28.6 m firm-wide (+£1.3–1.5 m incremental) |
| Exit criteria | Strategy must be reversed if, within 18 months, segment revenue has not reached £2.4 m annualised OR cumulative net profit contribution is below £150 k, OR if any lateral hire’s personal billings fall below 1 200 hours in any rolling 6-month period. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Go-to-Market & Commercial Strategy, one of 29 engagements the platform runs. For 律所 it works through 82 % realisation, 68 % utilisation, £184 k profit per equity partner and 112 lock-up days, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 在此阅读完整报告 if you would rather see the depth first.
唯一有意义的检验是终身价值与回款周期，两者都因具体业务而异。在一种模式下优秀的成本，在收入相同的另一种模式下可能致命。
长到覆盖你的销售周期加一个回款周期即可，不能再长。过早判断会杀死慢生效的渠道；过晚判断会继续资助永不回本的渠道。
先砍掉无法衡量的渠道——风险集中在那里。均匀削减会同时移除有效与无效的渠道。
Materially, yes. 19 of 28 equity partners aged 55 or over with no formal lateral hire programme or associate-to-partner track for eight years — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are 82 % realisation, 68 % utilisation, £184 k profit per equity partner, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on 82 % realisation and 68 % utilisation. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית